The global depression market is characterized by intense competition, driven by the persistent need for more effective treatments and the expiration of patents on older, blockbuster medications. Major pharmaceutical companies are engaged in a high-stakes race to innovate, focusing their research and development efforts on compounds with novel mechanisms of action that promise faster relief,...